The Single Best Strategy To Use For Lp-PLA2-IN-1
Contraindicated (one)bortezomib will improve the stage or impact of mavacamten by affecting hepatic enzyme CYP2C19 metabolism. Contraindicated. Strong or average CYP2C19 inhibitors may raise mavacamten systemic exposure, resulting in heart failure because of systolic dysfunction.
Drug Formulary i